- Evodiamine Mitigates Cellular Growth and Promotes Apoptosis by Targeting the c-Met Pathway in Prostate Cancer Cells
Sun Tae Hwang et al, 2020, Molecules CrossRef - MET expression during prostate cancer progression
Esther I. Verhoef et al, 2016, Oncotarget CrossRef - Androgen deprivation induces double-null prostate cancer via aberrant nuclear export and ribosomal biogenesis through HGF and Wnt activation
Won Kyung Kim et al, 2024, Nature Communications CrossRef - A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumors
David S. Hong et al, 2015, Oncotarget CrossRef - Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells
TIANCHENG LIU et al, 2014, International Journal of Oncology CrossRef - MET inhibition enhances PARP inhibitor efficacy in castration‐resistant prostate cancer by suppressing the ATM/ATR and PI3K/AKT pathways
Sihai Zhou et al, 2021, Journal of Cellular and Molecular Medicine CrossRef - Androgen deprivation of prostate cancer: Leading to a therapeutic dead end
Arndt Katzenwadel et al, 2015, Cancer Letters CrossRef - AR imposes different effects on ZFHX3 transcription depending on androgen status in prostate cancer cells
Xing Fu et al, 2022, Journal of Cellular and Molecular Medicine CrossRef - Testosterone Serum Levels and Prostate Cancer Prognosis: the Double Face of Janus
Francesca Valcamonico et al, 2014, Future Oncology CrossRef - Understanding the Mechanisms of Androgen Deprivation Resistance in Prostate Cancer at the Molecular Level
Theodoros Karantanos et al, 2015, European Urology CrossRef - Photoreactive Molecular Glue for Enhancing the Efficacy of DNA Aptamers by Temporary-to-Permanent Conjugation with Target Proteins
Ai Kohata et al, 2021, Journal of the American Chemical Society CrossRef - Evodiamine as the Active Compound of Evodiae fructus to Inhibit Proliferation and Migration of Prostate Cancer through PI3K/AKT/NF-κB Signaling Pathway
Yuhe Lei et al, 2022, Disease Markers CrossRef - Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial
Raya Leibowitz-Amit et al, 2016, Journal of Translational Medicine CrossRef - Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate Cancer
Yuanyuan Qiao et al, 2016, Neoplasia CrossRef - Crosstalk between RON and androgen receptor signaling in the development of castration resistant prostate cancer
Izhar Batth et al, 2016, Oncotarget CrossRef - Met in Urological Cancers
Yasuyoshi Miyata et al, 2014, Cancers CrossRef - c-Met expression and activity in urogenital cancers – novel aspects of signal transduction and medical implications
Ralf Hass et al, 2017, Cell Communication and Signaling CrossRef - The andrologist's contribution to a better life for ageing men: part 1
F. Comhaire et al, 2016, Andrologia CrossRef - Prostate cancer cells demonstrate unique metabolism and substrate adaptability acutely after androgen deprivation therapy
Mikolaj J. Filon et al, 2022, The Prostate CrossRef - Prolonged androgen deprivation leads to overexpression of calpain 2: Implications for prostate cancer progression
TIANCHENG LIU et al, 2014, International Journal of Oncology CrossRef